Clinical trial
Real-life-Persistence to Antifibrotic Treatments
NCT06485635 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-life-Persistence to Antifibrotic Treatments
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 16, 2024
- Completion date
- April 7, 2026
- Enrollment
- 10,646 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.